New Addition to Contract Research Organization WCCT Global’s Executive Team
COSTA MESA, Calif., February 18, 2013/PRWeb/–WCCT Global, a full-service contract research organization (CRO) supporting Phase I – IV biopharmaceutical and device development headquartered in Southern California, today welcomes Gary Urban as Executive Director, Corporate Compliance and Quality. As a Contract Research Organization professional for the past 16 years, Gary has held executive-level positions with global responsibility for Quality Management Systems, Clinical and Corporate Operations, and Information Technology. Gary earned a Bachelor of Science in Business Administration with a concentration in international business from Colorado Technical University. Gary is also certified in Good Clinical Practice and Lean Six Sigma Black Belt. When asked how Gary felt to be joining WCCT Global, he replied, “I am extremely excited to have joined this dynamic and growing organization, and look forward to leveraging my background in organizational optimization, leading companies successfully through growth and change, while ensuring the highest levels of quality, efficiency, and client and associate satisfaction.”
This is another great addition to the contract research organization because the service offering that WCCT Global is providing continues to grow which is why the firm is contacted by sponsors all over the world to perform clinical studies in many different therapeutic areas. The CRO firmly believes that it is not enough to merely have a general experience in therapeutics, which is why WCCT Global is pioneering expertise in multiple therapeutic areas such as Ophthalmology, Ethnobridging, and Influenza Challenge Research, and looks forward to continued clinical research in these fields. WCCT Global’s Chief Operating Officer Jon Rojas says, “Gary’s experience in I.T. and quality assurance allows WCCT Global to bring new technology, ensuring quality within our organization which in turn expands the breadth of services that we can offer to our clients.” On top of WCCT Global’s diversified therapeutic experience, they combine site ownership with a clinical pharmacology background to offer a unique service to sponsors that increases efficiency in reduces cost and timelines, helping to expedite the global drug development process.